These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

66 related articles for article (PubMed ID: 6118493)

  • 1. Reversal of benzodiazepine-induced sedation by intravenous Ro 15-1788.
    Darragh A; Lambe R; Brick I; Downie WW
    Lancet; 1981 Nov; 2(8254):1042. PubMed ID: 6118493
    [No Abstract]   [Full Text] [Related]  

  • 2. Investigation in man of the efficacy of a benzodiazepine antagonist, Ro 15-1788.
    Darragh A; Lambe R; Scully M; Brick I; O'Boyle C; Downe WW
    Lancet; 1981 Jul; 2(8236):8-10. PubMed ID: 6113428
    [No Abstract]   [Full Text] [Related]  

  • 3. Antagonism of the central effects of 3-methylclonazepam.
    Darragh A; Lambe R; Brick I; O'Boyle C
    Br J Clin Pharmacol; 1982 Dec; 14(6):871-2. PubMed ID: 6817773
    [No Abstract]   [Full Text] [Related]  

  • 4. Reversal of central benzodiazepine effects by flumazenil after conscious sedation produced by intravenous diazepam. The Flumazenil in Intravenous Conscious Sedation with Diazepam Multicenter Study Group I.
    Clin Ther; 1992; 14(6):895-909. PubMed ID: 1286497
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Assessment of the efficacy and tolerance of a benzodiazepine antagonist (Ro 15-1788)].
    Rouiller M; Forster A; Gemperle M
    Ann Fr Anesth Reanim; 1987; 6(1):1-6. PubMed ID: 3107442
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Reversal of central nervous system effects by flumazenil after intravenous conscious sedation with midazolam: report of a multicenter clinical study. The Flumazenil in Intravenous Conscious Sedation with Midazolam Multicenter Study Group I.
    Clin Ther; 1992; 14(6):861-77. PubMed ID: 1286495
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Effect of benzodiazepines on interneuronal transmission in afferent systems and their antagonism with Ro 15-1788].
    Kharkevich DA; Sinitsyn LN; Churiukanov VV; Fisenko VP; Chichenikov ON
    Farmakol Toksikol; 1983; 46(5):14-9. PubMed ID: 6138277
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effects of a benzodiazepine antagonist on the diazepam-induced electrical brain activity modifications.
    Laurian S; Gaillard JM; Le PK; Schöpf J
    Neuropsychobiology; 1984; 11(1):55-8. PubMed ID: 6429564
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The anxiolytic but not the sedative properties of tracazolate are reversed by the benzodiazepine receptor antagonist, Ro 15-1788.
    File SE; Pellow S
    Neuropsychobiology; 1985; 14(4):193-7. PubMed ID: 2872613
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Reversal of slow-wave sleep by benzodiazepine antagonist Ro 15-1788.
    Ziegler G; Ludwig L; Fritz G
    Lancet; 1985 Aug; 2(8453):510. PubMed ID: 2863538
    [No Abstract]   [Full Text] [Related]  

  • 11. Reversal of central benzodiazepine effects by flumazenil after intravenous conscious sedation with diazepam and opioids: report of a double-blind multicenter study. The Flumazenil in Intravenous Conscious Sedation with Diazepam Multicenter Study Group II.
    Clin Ther; 1992; 14(6):910-23. PubMed ID: 1286498
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Pharmacokinetics of the selective benzodiazepine antagonist Ro 15-1788 in man.
    Klotz U; Ziegler G; Reimann IW
    Eur J Clin Pharmacol; 1984; 27(1):115-7. PubMed ID: 6436030
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effects of flunitrazepam on memory and their reversal by two antagonists.
    Gentil V; Gorenstein C; Camargo CH; Singer JM
    J Clin Psychopharmacol; 1989 Jun; 9(3):191-7. PubMed ID: 2500462
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Intrinsic activity of the benzodiazepine antagonist Ro 15-1788 in man: an electrophysiological investigation.
    Schöpf J; Laurian S; Le PK; Gaillard JM
    Pharmacopsychiatry; 1984 May; 17(3):79-83. PubMed ID: 6429677
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Interaction of the benzodiazepine antagonists, CGS 8216 and Ro 15-1788, with central adenosine A-1 receptors.
    Williams M; Risley EA
    Arch Int Pharmacodyn Ther; 1982 Nov; 260(1):50-3. PubMed ID: 6299218
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Reversal of the central effects of midazolam by intravenous flumazenil after general anesthesia in outpatients: a multicenter double-blind clinical study. The Flumazenil in General Anesthesia in Outpatients Study Group I.
    Clin Ther; 1992; 14(6):966-77. PubMed ID: 1286502
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Blockade of behavioral effects of bretazenil by flumazenil and ZK 93,426 in pigeons.
    Witkin JM; Acri JB; Gleeson S; Barrett JE
    Pharmacol Biochem Behav; 1997 Jan; 56(1):1-7. PubMed ID: 8981602
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Reversal of the central effects of midazolam by intravenous flumazenil after general anesthesia and use of a long-acting opioid in hospitalized patients: report of a multicenter double-blind clinical study. The Flumazenil in General Anesthesia in Hospitalized Patients Study Group II.
    Clin Ther; 1992; 14(6):939-53. PubMed ID: 1286500
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Tetrazepam: a benzodiazepine which dissociates sedation from other benzodiazepine activities. I. Psychopharmacological profile in rodents.
    Keane PE; Simiand J; Morre M; Biziere K
    J Pharmacol Exp Ther; 1988 May; 245(2):692-8. PubMed ID: 2896794
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Differentiation of drug-induced rhythmical activities in the rabbit's brain by a benzodiazepine antagonist.
    Gogolák G; Stumpf C; Huck S
    Arzneimittelforschung; 1985; 35(1A):233-6. PubMed ID: 2859027
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.